GENE ONLINE|News &
Opinion
Blog

2025-04-22|

Lawsuit Accuses Sam Waksal of Giving Veterinary Drug to Sick Child

by Mark Chiang
Share To

NEWSFLASH

A new lawsuit accuses biotech entrepreneur Sam Waksal of “reckless conduct,” specifically alleging he administered a veterinary medicine, unapproved for human use, to a seriously ill child. The lawsuit details the accusations against Waksal. According to the lawsuit, the alleged incident involves Waksal using a medication intended for animals on a child facing severe health challenges. The legal action centers on the claim that Waksal acted recklessly in administering a drug not approved for human consumption. Further details about the child’s illness, the specific veterinary medicine used, and the circumstances surrounding its administration are expected to emerge as the case progresses.

Newsflash | Powered by GeneOnline AI
Date: April 22, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top